Dynamic Advisor Solutions LLC bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 21,366 shares of the healthcare conglomerate’s stock, valued at approximately $11,190,000.
Several other hedge funds and other institutional investors have also bought and sold shares of UNH. NewSquare Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $25,000. Marshall & Sterling Wealth Advisors Inc. acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $26,000. Hurley Capital LLC acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $28,000. Aster Capital Management DIFC Ltd acquired a new position in shares of UnitedHealth Group during the fourth quarter valued at about $30,000. Finally, Promus Capital LLC acquired a new stake in shares of UnitedHealth Group in the 4th quarter worth about $32,000. Institutional investors and hedge funds own 87.86% of the company’s stock.
UnitedHealth Group Stock Down 1.6%
UNH opened at $313.39 on Friday. The company has a 50 day moving average of $386.66 and a 200 day moving average of $473.26. The company has a market cap of $284.28 billion, a PE ratio of 20.22, a price-to-earnings-growth ratio of 1.37 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $248.88 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74.
UnitedHealth Group Increases Dividend
The company also recently announced a quarterly dividend, which will be paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th will be paid a $2.21 dividend. The ex-dividend date of this dividend is Monday, June 16th. This is a boost from UnitedHealth Group’s previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 2.82%. UnitedHealth Group’s dividend payout ratio is currently 37.02%.
Analyst Ratings Changes
A number of equities research analysts recently weighed in on UNH shares. HSBC restated a “reduce” rating and issued a $270.00 target price (down previously from $490.00) on shares of UnitedHealth Group in a report on Wednesday, May 21st. Baird R W lowered shares of UnitedHealth Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday. Morgan Stanley lowered their target price on shares of UnitedHealth Group from $563.00 to $374.00 and set an “overweight” rating on the stock in a report on Wednesday, May 14th. Truist Financial reaffirmed a “buy” rating and issued a $360.00 price objective (down from $580.00) on shares of UnitedHealth Group in a research report on Monday, May 19th. Finally, Bank of America downgraded shares of UnitedHealth Group from a “buy” rating to a “neutral” rating and reduced their price objective for the stock from $560.00 to $350.00 in a research report on Wednesday, May 14th. One research analyst has rated the stock with a sell rating, nine have given a hold rating and sixteen have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $426.52.
Get Our Latest Report on UnitedHealth Group
Insiders Place Their Bets
In related news, Director Timothy Patrick Flynn acquired 1,533 shares of the stock in a transaction dated Wednesday, May 14th. The shares were purchased at an average price of $320.80 per share, for a total transaction of $491,786.40. Following the transaction, the director now owns 6,033 shares in the company, valued at $1,935,386.40. This represents a 34.07% increase in their position. The acquisition was disclosed in a document filed with the SEC, which is available through the SEC website. Also, CEO Patrick Hugh Conway sold 589 shares of the firm’s stock in a transaction on Tuesday, June 10th. The shares were sold at an average price of $305.00, for a total transaction of $179,645.00. Following the sale, the chief executive officer now owns 10,398 shares in the company, valued at approximately $3,171,390. This trade represents a 5.36% decrease in their position. The disclosure for this sale can be found here. Insiders have bought 109,408 shares of company stock worth $31,607,768 in the last three months. 0.28% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
Featured Articles
- Five stocks we like better than UnitedHealth Group
- What is the Dogs of the Dow Strategy? Overview and Examples
- Synopsys Stock Falls on China Ban, But Long-Term Outlook Holds
- What Is WallStreetBets and What Stocks Are They Targeting?
- Alphabet Enters a Bull Market: Is It Time to Buy?
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Ouster Soars 27% as DoD Grants First 3D LiDAR Approval for Drones
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.